GENELUX Corp (GNLX) SEC filings

Name: GENELUX Corp (GNLX) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0001231457 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

	FY2025	FY2024	FY2023
Revenue (USD)	8000	170000	11.1 M
Net income (USD)	-32.1 M	-28.3 M	-5.2 M
Diluted EPS (USD/shares)	-0.86	-1.16	-0.57

Latest filings

Filed	Form	Description	Period
2026-09-02	4	4	2026-08-31
2026-09-02	4	4	2026-08-31
2026-09-02	4	4	2026-08-31
2026-08-13	10-Q	10-Q	2026-06-30
2026-08-04	4	4	2026-08-04
2026-08-04	4	4	2026-08-04
2026-08-04	4	4	2026-08-04
2026-07-02	4	4	2026-07-01
2026-07-01	144	144
2026-06-22	8-K	8-K items 5.07	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-18	4	4	2026-06-16
2026-06-04	4	4	2026-06-03
2026-06-02	4	4	2026-06-01
2026-06-01	144	144
2026-05-12	4	4	2026-05-11
2026-05-12	4	4	2026-05-11
2026-05-12	4	4	2026-05-11

Forms on file (last 1,000): 4 163, 144 35, 8-K 31, 3 19, 10-Q 11, CORRESP 9, UPLOAD 7, 424B5 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=GNLX (0.002 USD), /gw/filings/filings?ticker=GNLX&form=8-K, /gw/filings/facts?ticker=GNLX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange